AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution

Breakthrough wearable heart failure therapy enables earlier hospital discharge: UK trial

Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process

Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers

High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments

AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management

Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure

Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC

Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets

Eli Lilly launches Lormalzi for early Alzheimer’s treatment in India

Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence

Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics

The two companies will establish a joint Center of Excellence (CoE) in Bengaluru